Opioids remain a cornerstone for managing moderate to severe pain during labour and the immediate postpartum period. In Nigerian midwifery practice, understanding when and how to administer these medications ensures that a labouring mother receives adequate pain relief without compromising her safety or that of her unborn baby. These drugs work primarily by altering the perception of pain within the central nervous system. Because they readily cross the placental barrier, every dose administered to a mother directly affects the foetus. Midwives must weigh the benefits of maternal pain relief against the potential risks of neonatal respiratory depression. Familiarity with local hospital guidelines and standing orders is essential before prescribing or administering any opioid analgesic on the labour ward.
Opioids exert their powerful analgesic effects by binding to specific receptors located throughout the brain, spinal cord, and peripheral tissues. The three main receptor types are mu, kappa, and delta, with mu receptors playing the primary role in pain relief, euphoria, and respiratory depression. When an opioid binds to these sites, it inhibits the transmission of nociceptive signals. Beyond pain reduction, activation of these receptors triggers several systemic responses.
Morphine is a potent, naturally occurring opioid alkaloid used primarily for severe pain during the first stage of labour or for postpartum pain relief, such as following a caesarean section. It can be administered via intramuscular, intravenous, or subcutaneous routes. Intravenous administration provides rapid relief but demands careful observation due to the sudden peak in drug concentration. A common misconception on busy wards is that morphine can be given safely at any point in active labour; however, if delivery is anticipated within two to four hours, alternative pain management should be considered to protect the neonate. Midwives must always ensure that naloxone is readily accessible in the treatment room before drawing up morphine.
Pethidine (also known as meperidine) has historically been one of the most widely used opioids for pain relief during the first stage of labour in Nigerian health facilities. It provides moderate analgesia and creates a sense of detachment from pain, which helps some mothers relax between contractions. Pethidine is usually given intramuscularly, with peak action occurring around forty to sixty minutes after injection.
A major pharmacokinetic drawback of pethidine is its active metabolite, norpethidine, which has a long half-life and can accumulate in both maternal and neonatal systems. Norpethidine is a central nervous system stimulant that can trigger tremors or seizures and remains in the newborn's body much longer than the parent drug, sometimes causing delayed respiratory depression hours after birth.
Using opioids in obstetric care carries a dual profile of side effects affecting both the mother and the newborn. Maternal side effects frequently include nausea, vomiting, dizziness, excessive sedation, and delayed gastric emptying, which increases the risk of aspiration if general anaesthesia becomes necessary. Antiemetics are often prescribed alongside opioids to control nausea.
For the neonate, the most critical risk is neonatal respiratory depression, characterized by a slow, shallow breathing rate, low Apgar scores, and poor muscle tone at birth. Babies experiencing opioid depression may also show a temporary inability to latch and suck effectively during early breastfeeding initiation, requiring extra patience and support from the midwifery team.
When an opioid overdose or severe neonatal depression occurs, immediate reversal is vital. Naloxone is a pure opioid antagonist that competitively blocks mu receptors, quickly displacing the opioid molecules and reversing respiratory depression. It can be administered intravenously, intramuscularly, or subcutaneously to the mother, or via the umbilical vein in severe neonatal emergencies.
Midwives must remember that naloxone has a relatively short duration of action—often wearing off in thirty to forty-five minutes. Because many opioids last much longer in the body than naloxone, the patient can slip back into respiratory depression once the antagonist wears off. Continuous observation and repeat doses are frequently necessary.
Safe administration of opioids requires rigorous monitoring protocols in every labour ward and postnatal unit. Midwives must record baseline vital signs—specifically respiratory rate, blood pressure, and level of consciousness—before giving any opioid dose. Following administration, respiratory rate must be checked every fifteen to thirty minutes for at least two hours. Any respiratory rate dropping below twelve breaths per minute serves as an immediate warning sign requiring clinical intervention.
Clear documentation of the exact time, dose, and route of administration prevents accidental double-dosing. Furthermore, resuscitating equipment, functional suction machines, and weight-appropriate neonatal masks must be tested and placed at the bedside before any pain medication is handed to the mother.